4//SEC Filing
ContraVir Pharmaceuticals, Inc. 4
Accession 0001104659-17-040822
$HEPACIK 0001583771operating
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 9:00 AM ET
Size
4.4 KB
Accession
0001104659-17-040822
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Purchase
Common Stock
2017-06-20$0.65/sh+20,000$13,000→ 20,000 total
Documents
Issuer
ContraVir Pharmaceuticals, Inc.
CIK 0001583771
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001583771
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 9:00 AM ET
- Size
- 4.4 KB